SCHEMBL3985653

SCHEMBL3985653

COc1ccc(C=O)c(-c2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DCK P27707 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310972 0.78 DCK (0.71) DCK
SCHEMBL311256 0.77 DCK (0.73) DCK
SCHEMBL311549 0.77 DCK (0.68) DCK
SCHEMBL311500 0.77 DCK (0.72) DCK
SCHEMBL311697 0.75 DCK (0.69) DCK
SCHEMBL10172445 0.74 DCK (0.71) DCK
SCHEMBL10172447 0.73 DCK (0.66) DCK
SCHEMBL10172450 0.70 DCK (0.59) DCK
SCHEMBL10172496 0.70 DCK (0.75) DCK
SCHEMBL10172513 0.70 DCK (0.83) DCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2104672-A2 2-(PIPERIDIN-4-YL0XY)PYRIMIDIN-4-AMINE DERIVATIVES AS DEOXYCYTIDINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER Lexicon Pharmaceuticals, Inc. (US) 2009-09-30 EP disclosed
WO-2008076779-A2 2-(PIPERIDIN-4-YL0XY)PYRIMIDIN-4-AMINE DERIVATIVES AS DEOXYCYTIDINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER LEXICON PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed